AllianceBernstein’s ACELYRIN SLRN Stock Holding History

AllianceBernstein’s Portfolio SLRN Stock Details SLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-73,670	Closed	-$182K	–	3323
2025 Q1	$182K	Hold	73,670	–	–	﹤0.01%	2946
2024 Q4	$231K	Hold	73,670	–	–	﹤0.01%	2987
2024 Q3	$363K	Hold	73,670	–	–	﹤0.01%	2815
2024 Q2	$325K	Buy	73,670 +16,940	+30%	+$79.4K	﹤0.01%	2884
2024 Q1	$383K	Buy	56,730 +31,800	+128%	+$242K	﹤0.01%	2704
2023 Q4	$186K	Hold	24,930	–	–	﹤0.01%	2993
2023 Q3	$254K	Sell	24,930 -1,118,344	-98%	-$23.8M	﹤0.01%	2882
2023 Q2	$23.9M	Buy	+1,143,274	New	+$23.4M	0.01%	796

Other funds holding SLRN

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

AllianceBernstein's SLRN Position: Q2 2025 in Review

AllianceBernstein sold out of ACELYRIN (SLRN) in Q2 2025, closing a stake of 73,670 shares — an estimated $182K sold.

AllianceBernstein first reported a position in SLRN in Q2 2023 and held it in 8 quarters. The position peaked at $23.9M in Q2 2023. 2 funds tracked by Wall St. Rank hold SLRN as of Q2 2025.

AllianceBernstein reported no remaining ACELYRIN position as of Q2 2025 after selling out during the quarter.
AllianceBernstein sold 73,670 ACELYRIN shares in Q2 2025, an estimated $182K.
AllianceBernstein first reported a position in ACELYRIN in Q2 2023 and held it in 8 quarters.
AllianceBernstein's ACELYRIN position peaked at $23.9M in Q2 2023.
2 funds tracked by Wall St. Rank held ACELYRIN as of Q2 2025.

Based on AllianceBernstein's 13F filing for Q2 2025, filed 14 Aug 2025.